Jardian Tablet 25 mg contains Empagliflozin, an oral antidiabetic medicine belonging to the class of Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitors. It is primarily used in the management of type 2 diabetes mellitus in adults. Empagliflozin helps improve blood glucose control by promoting the excretion of excess glucose through the urine, offering an insulin-independent mechanism of action.

Jardian Tablet 25 mg is often prescribed when diet and exercise alone are not sufficient to control blood sugar levels. It may be used as monotherapy or in combination with other antidiabetic agents such as metformin, insulin, or sulfonylureas. In addition to glycemic control, empagliflozin has shown beneficial effects on body weight and cardiovascular outcomes, making it a valuable option in comprehensive diabetes care.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Empagliflozin 25 mg

Therapeutic Class

• Antidiabetic Agent

• SGLT2 Inhibitor

Indications and Uses

Jardian Tablet 25 mg is indicated for:

• Management of type 2 diabetes mellitus in adults

• Improving glycemic control along with diet and exercise

• Use as monotherapy or combination therapy with other antidiabetic medicines

• Reducing the risk of cardiovascular complications in selected patients with type 2 diabetes, as advised by a physician

Mechanism of Action

Empagliflozin selectively inhibits the SGLT2 protein in the proximal renal tubules of the kidneys. This inhibition reduces glucose reabsorption and increases urinary glucose excretion, leading to lower blood glucose levels. Since this action is independent of insulin secretion, the risk of hypoglycemia is low when used alone.

Key Benefits

• Effective reduction of fasting and postprandial blood glucose

• Insulin-independent mechanism of action

• Supports weight reduction due to calorie loss through glucose excretion

• Low risk of hypoglycemia when used alone

• Once-daily oral dosing for better patient compliance

Dosage and Administration

• Usually taken once daily, with or without food

• Dose selection depends on individual glycemic control and renal function

• To be used strictly as prescribed by a healthcare professional

• Regular monitoring of blood glucose and kidney function is recommended

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not indicated for type 1 diabetes mellitus or diabetic ketoacidosis

• Use with caution in patients with renal impairment, dehydration, or hypotension

• Adequate hydration should be maintained during therapy

• Risk of urinary tract and genital infections may be increased

• Not recommended during pregnancy and breastfeeding unless clearly indicated

Adverse Effects

Common adverse effects may include increased urination, thirst, urinary tract infections, and genital fungal infections. Most side effects are mild to moderate and can be managed with appropriate medical care and hygiene measures.

Storage Conditions

• Store below 30°C

• Protect from moisture and direct sunlight

• Keep out of reach of children

Conclusion

Jardian Tablet 25 mg (Empagliflozin) is a modern and effective oral antidiabetic medication that offers reliable blood glucose control along with additional metabolic and cardiovascular benefits. When used as part of a structured diabetes management plan under medical supervision, it contributes significantly to improved long-term outcomes in patients with type 2 diabetes.